Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Eupraxia Pharmaceuticals Inc. EPRX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CA • USD

SharesGrow Score
54/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$19.00
+156.8%

EPRX Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for EPRX.

People Also View

SLS
SLS
SELLAS Life Sciences Group, Inc.
$4.91
+1.03%
 GNFT
GNFT
Genfit S.A.
$8.95
+4.07%
 NAUT
NAUT
Nautilus Biotechnology, Inc.
$3.25
+6.21%
 IVA
IVA
Inventiva S.A.
$5.74
+4.17%
 OBIO
OBIO
Orchestra BioMed Holdings, Inc.
$4.57
+1.33%
 TARA
TARA
Protara Therapeutics, Inc.
$5.21
+1.56%
 MDWD
MDWD
MediWound Ltd.
$17.25
-2.54%
 RNAC
RNAC
Cartesian Therapeutics, Inc.
$5.99
-5.67%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message